Basic Information
PANTIN 40 PANTOPRAZOLE GASTRO-RESISTANT TABLETS 40 MG
TABLET, ENTERIC COATED
Regulatory Information
SIN15041P
July 4, 2016
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XA02BC02
Company Information
Active Ingredients
Strength: 40.0 mg
Detailed Information
Contraindications
**CONTRAINDICATIONS** Pantoprazole gasro-resistent tablets must not be used in cases of known hypersensitivity to the active ingredient or/and any of the other constituents of Pantoprazole gasro-resistent tablets. Pantoprazole, like other PPIs, should not be co-administered with atazanavir (see Interaction with other medicinal products and other forms of interaction).
Indication Information
**INDICATION AND USAGE** Pantoprazole Gastro-Resistant Tablets 20mg: Mild reflux disease and associated symptoms (e.g. heartburn, acid regurgitation, pain on swallowing). Long-term management and prevention of relapse in reflux oesophagitis. Pantoprazole Gastro-Resistant Tablets 40mg: Moderate and severe reflux oesophagitis.